US20040215005A1 - Chitosan preparation - Google Patents

Chitosan preparation Download PDF

Info

Publication number
US20040215005A1
US20040215005A1 US10/485,062 US48506204A US2004215005A1 US 20040215005 A1 US20040215005 A1 US 20040215005A1 US 48506204 A US48506204 A US 48506204A US 2004215005 A1 US2004215005 A1 US 2004215005A1
Authority
US
United States
Prior art keywords
chitin
chitosan
swelling
hours
deacetylation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/485,062
Other languages
English (en)
Inventor
Kjell Varum
Olav Smidsrod
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Biopolymers AS
Original Assignee
Advanced Biopolymers AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NO20013802A external-priority patent/NO20013802D0/no
Application filed by Advanced Biopolymers AS filed Critical Advanced Biopolymers AS
Assigned to ADVANCED BIOPOLYMERS AS reassignment ADVANCED BIOPOLYMERS AS ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SMIDSROD, OLAV, VARUM, KJELL MORTEN
Publication of US20040215005A1 publication Critical patent/US20040215005A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Definitions

  • the invention relates to a process for the preparation of chitosan and to novel chitosan products produced thereby as well as their uses.
  • Chitin is a natural nitrogenous mucopolysaccharide of formula (C 8 H 13 N 5 ) n which occurs in the exoskeletons of invertebrates and also in funghi. In particular it is a major component of the exoskeletons of crustacea such as shrimp, crab, prawn and lobster. More particularly chitin is poly N-acetyl-D-glucosamine. Thus chitin consists of (1 ⁇ 4)-linked 2-acetamido-2-deoxy- ⁇ -D-glucose (GlcNac; the A-unit).
  • ⁇ -chitin The physical structure of chitin is highly ordered, and the most abundant form is ⁇ -chitin which is available as a waste material from the shellfish food industry.
  • ⁇ -chitin the chains are antiparallel, and extensively hydrogen-bonded.
  • ⁇ -chitin Another form is ⁇ -chitin, which can be isolated from, for example the pen of the squid Loligo and the spines of the diatom Thalassiosira fluviatilis .
  • ⁇ -chitin the chains are parallel, and the chains are less hydrogen-bonded compared with ⁇ -chitin.
  • Chitosan has many known uses, e.g. in pharmaceutical and cosmetic compositions, and as fillers, absorbants, carriers and supports.
  • Chitosan may be regarded as a family of water-soluble polysaccharides consisting of (1 ⁇ 4)-linked A-units and units of 2-amino-2-deoxy- ⁇ -D-glucose (GlcN; the D-unit) in varying relative abundances and sequences.
  • chitosan is related to the fact that chitosans are generally only soluble in water when the free amino groups of D-units are protonated. Such protonation can be achieved by the addition of a controlled amount of an acid, e.g. acetic acid.
  • chitosan can also be prepared in different salt forms, i.e. with a protonated amino-group in the D-units and a negatively charged counterion (e.g. formate, acetate, chloride or another negative ion), which make it soluble in water without the addition of an acid.
  • a negatively charged counterion e.g. formate, acetate, chloride or another negative ion
  • FA the relative fraction of the saccharide units which are A rather than D units.
  • chitosan can be produced with a wide range of degrees of acetylation and a wide range of molecular weights.
  • one remaining problem with commercially available chitosan is its insolubility at physiological pH values.
  • the production of chitosan from chitin is generally carried out as either a homogeneous reaction or as a heterogeneous reaction.
  • chitin is suspended in alkali and the suspension is cooled with ice to bring the chitin into solution; in the heterogeneous reaction particulate chitin is dispersed in a hot alkaline solution, generally sodium hydroxide.
  • the F A of the chitosan obtained is generally 0.3 to 0.7.
  • the F A of the chitosan obtained is generally in the range of 0 to 0.15.
  • a chitosan with a different degree of deacetylation it may be necessary to re-acetylate the chitosan.
  • the remaining N-acetyl groups are generally randomly located along the polymeric backbone of the chitosan product.
  • a small fraction of insoluble chitin-like material is most often present in the product together with an acid-soluble fraction with a near random distribution of acetyl groups along the polymeric backbones.
  • the reacetylation of a highly deacetylated chitosan involves solubilization of the chitosan, use of organic chemicals such as acetic anhydride and methanol, and isolation of the final product.
  • the homogeneous deacetylation procedure involves solubilisation of the chitin by addition of ice, and isolation of the chitosan from the solution. Moreover, to avoid the chitin solution having too high a viscosity, large volumes of aqueous lye are needed in the reaction medium. This homogeneous deacetylation procedure therefore results in a more expensive product compared to the product of a heterogeneous deacetylation procedure.
  • a chitosan product may be obtained with a more random distribution of residual N-acetyl groups along the polymeric chains, with a degree of deacetylation which can be as low or high as desired, with a degree of depolymerisation which may if desired be lower than in the conventional products, and if desired with an enhanced water-solubility at physiological pHs.
  • the invention provides a process for the preparation of chitosan which process comprises swelling particulate chitin with an aqueous solution, preferably an aqueous alkaline solution, at a temperature below 30° C. and for a period of at least 36 hours, and subsequently reacting the resultant swollen particulate chitin with an alkaline solution at an elevated temperature whereby to cause deacetylation to occur, e.g. to a predetermined desired F A value, and if desired yielding a fully water-soluble chitosan.
  • an aqueous solution preferably an aqueous alkaline solution
  • the chitin used in the process of the invention is preferably chitin extracted from invertebrate exoskeletons, e.g. by deproteinisation and demineralisation.
  • the chitin is preferably ⁇ -chitin.
  • this chitin is extracted from crustacean exoskeletons, particularly shrimp, krill, lobster or crab exoskeletons and clam shells.
  • shrimp is used herein to denote both prawn and shrimp as well as similar species such as scampi.
  • lobster is used herein to denote both lobster and similar species such as crayfish and langoustine. Exoskeletons from arctic prawn ( Pandalus borealis ) are especially preferred.
  • crustacean exoskeletons are available as a waste product in the food production industry.
  • the chitin used as the starting material is preferably isolated from crustacean shells (e.g. shrimp, clam, krill, crab and lobster shell)
  • other chitin sources may be used in the process of the invention, e.g. ⁇ -chitin from sources such as squid pens and diatoms.
  • other chitins, such as ⁇ -chitin may also be used.
  • the chitin starting material can be in a crude or pre-treated form, e.g. optionally dried and further mechanically and/or chemically modified.
  • the chitin is preferably in flake or powder form, e.g. having a mode particle size of 5 to 1000 ⁇ m, especially 50 to 500 ⁇ m. Such powders are desirably substantially uniform in particle size.
  • the particulate chitin is swollen in an aqueous solution, preferably an alkaline solution, e.g. an at least 10N alkali solution, and/or a solution containing dissolved electrolyte/salts which are able to disrupt the crystalline structures in the chitin.
  • the solution preferably has a polar or protic solvent, e.g. water, an alcohol (for example methanol), dimethylsulphoxide, dimethylformamide, dimethylacetamide or acetonitrile.
  • An aqueous alkaline solution is especially preferably used as its environmental impact is lower.
  • the alkali used may be any alkali capable of deacetylating chitin but is preferably an inorganic alkali, in particular an alkali or alkaline earth metal hydroxide, e.g. potassium hydroxide but especially sodium hydroxide.
  • the alkali is preferably a so-called strong base. Lye is especially preferably used.
  • the alkaline solution desirably has a pH equivalent to or greater than that of aqueous 10M NaOH, more preferably that of 15M NaOH.
  • at least 15 M sodium hydroxide, especially at least 18 M sodium hydroxide will be used, e.g. 15 to 25M more preferably 18 to 22M.
  • the alkaline solution will generally be used in a weight ratio relative to the particulate chitin of 100:1 to 1:1, preferably 50:1 to 4:1, more preferably 30:1 to 8:1.
  • the chitin is contacted with a liquid comprising an organic solvent in which chitin is soluble.
  • the liquid may contain water as a cosolvent and water may be added to the chitin liquid mixture to precipitate the dissolved chitin as swollen amorphous particles.
  • Such liquid is desirably alkaline but may contain other dissolved components, e.g. electrolytes/salts, which are able to disrupt the crystalline structures in the chitin.
  • One such liquid that may be used in this regard is an aqueous methanolic solution of calcium chloride.
  • the swelling stage of the process of the invention is preferably performed at a temperature of up to 30° C., e.g. ⁇ 6 to 30° C., more preferably 0 to 30° C., especially 15 to 25° C., in particular up to 20° C.
  • the chitin is brought into solution-by cooling to ice temperatures, where the swelling according to the process of the invention is effected at temperatures of 5° C. or lower it is terminated before the chitin dissolves and the material which is subjected to the alkaline deacetylation at elevated temperature is a particulate, undissolved, swollen chitin.
  • the swelling stage is preferably effected for at least 48 hours (e.g. 48 to 75 hours), more preferably at least 54 hours, especially 60 to 120 hours, more especially 65 to 75 hours.
  • the swelling period is extended, the percentage yield of acid-soluble chitosan produced in a subsequent deacetylation increases; above 75 hours the further increase in yield is small.
  • the swelling time required for ⁇ -chitin will be less than that for ⁇ -chitin.
  • the swelling of the chitin may be accelerated by exposing the chitin during swelling to pressure or irradiation, e.g. by crushing or extruding moist chitin or by microwave or ultrasound irradiation.
  • pressure or irradiation e.g. by crushing or extruding moist chitin or by microwave or ultrasound irradiation.
  • This is a novel aspect of chitin to chitosan conversion and thus viewed from a further aspect the invention provides a process for the preparation of chitosan which process comprises swelling particulate chitin with an aqueous solution (preferably an alkaline solution) at a temperature below 30° C. and with the application of pressure or irradiation to accelerate the swelling, and subsequently reacting the resultant swollen particulate chitin with an alkaline solution at an elevated temperature whereby to cause deacetylation to occur.
  • an aqueous solution preferably an alkaline solution
  • the swelling time is selected to be a time sufficient for the chitin to become swollen amorphous chitin, i.e. chitin essentially free from crystalline domains. This can be verified experimentally by X-ray diffraction.
  • chitin is in the swollen amorphous state when it has swollen in volume by at least 1.4 times the volume the chitin has in distilled water, preferably at least 1.5 times.
  • the alkaline deacetylation of amorphous chitin is itself novel and forms a further aspect of the present invention.
  • the invention provides a process for the preparation of chitosan comprising reacting particulate amorphous chitin, preferably swollen with an aqueous alkaline solution, with an aqueous alkaline solution at an elevated temperature, e.g. above 30° C., preferably above 40° C.
  • the amorphous chitin used in this process may be produced by swelling as described herein or by precipitation of dissolved chitin.
  • the swollen chitin is subjected to alkaline deacetylation at a higher temperature than was used in the swelling stage, e.g. at least 5° C. higher preferably at least 25° C. higher.
  • the temperature in the deacetylation stage is at least 40° C. up to the boiling point of the solution (e.g. up to 130° C.), preferably at least 45° C., e.g. in the range 45 to 120° C., more especially 50 to 70° C., particularly 55 to 65° C.
  • the effect of increasing the temperature is to reduce the time required to produce a desired degree of deacetylation.
  • the process of the invention is preferably effected so as to yield chitosan having a predetermined F A value
  • the process will normally involve exposure to the increased deacetylation temperatures for a predetermined time.
  • the deacetylation reaction will be run for from 30 minutes to 10 hours, preferably 45 minutes to 4 hours.
  • the alkaline solution used in the deacetylation stage may be the same as the solution used in the swelling stage, optionally with further alkali being added or with excess alkali being removed.
  • the swollen chitin may be recovered and contacted with fresh alkali solution.
  • Such further or fresh alkali solution may be as described above for the swelling stage.
  • the deacetylation stage will generally be carried out using the same alkaline solution as the swelling stage, optionally with further alkaline solution being added.
  • the deacetylation is preferably effected so as to give a chitosan product having an F A of 0.2 to 0.7, especially 0.45 to 0.6.
  • the chitosan product will generally be washed, and optionally dried, and milled, e.g. as in conventional chitosan production processes. If desired it can be separated from any residual chitin by acid extraction and precipitation; again this may be effected as in conventional chitosan production processes.
  • the washing of the chitosan product will typically be carried out with warm water (e.g. 30 to 70° C.) and continued until the washing solution reaches pH neutral. Washing with cold water should generally be avoided as gel formation may occur.
  • warm water e.g. 30 to 70° C.
  • the process is a process for the production of fully water-soluble chitosan, with a predetermined fraction of acetylated amino groups (F A ), by swelling and subsequent deacetylation, characterized in that it comprises:
  • step (b) isolation of the chitosan by washing the deacetylated chitin from step (b) with water until the washing solution becomes neutral, and optionally drying and milling the chitosan product.
  • an essentially distinguishing feature of the present invention is that it is possible to produce a product which is fully water-soluble, avoiding the need to extract the product with an acid in order to separate the unreacted chitin from the water-soluble chitosan.
  • chitosan that can be fully dissolved, that is more than 97% wt dissolved in a dilute acid solution, for example as a 1% w/v solution of the chitosan in 1% w/v acetic acid.
  • the temperatures and durations of the swelling and deacetylation stages required to produce chitosan having a desired degree of deacetylation may be determined by routine experimentation.
  • swelling of ⁇ -chitin from Pandalus borealis at 20° C. for 66 to 100 hours, followed by deacetylation at 50° C. for 3 hours or 60° C. for 1 hour yields chitosan with an F A of about 0.5.
  • the process of the invention will typically involve swelling for a predetermined time at a predetermined temperature followed by deacetylation for a predetermined time at a predetermined temperature, to produce a product of desired F A .
  • the times and temperatures may be adjusted in a feedback control system which involves monitoring the properties of the reaction medium, e.g. by sampling and testing.
  • the invention provides a process for the preparation of chitosan which process comprises swelling particulate chitin with an alkaline solution at a temperature below 30° C. for a period of at least 65 to 1000 hours, and subsequently extracting chitosan from the reaction mixture.
  • the low temperature swelling transforms the chitin from its natural state which contains crystalline regions separated by amorphous regions to one in which the chitin is essentially entirely amorphous.
  • This transformation e.g. at 10-25° C. in 10-25N alkali solution (for example 20M NaOH), generally takes about 36-80 hours.
  • the process can be followed by monitoring the swelling of the chitin or by X-ray diffraction. As swelling comes to an end, the deacetylation begins. Generally once swelling terminates it takes about 90 hours more for the F A to reach about 0.5, about 250 hours to reach 0.3 and about 600 hours to reach 0.05.
  • the process can be performed so as to achieve the degree of deacetylation required simply by selecting the pH, temperature and duration of the alkali treatment.
  • the essentially amorphous chitin produced as an intermediate in this process is itself novel and forms a further aspect of the invention.
  • the invention provides amorphous (i.e. non-crystalline) chitin, especially swollen amorphous chitin.
  • the invention provides a process for the production of chitosan comprising reacting amorphous chitin with an aqueous alkali.
  • the medium range degree of deacetylation chitosans produced using the processes of the invention in this way have enhanced water solubility at physiological or near physiological pH and form a further aspect of the invention.
  • Such chitosans may be distinguished from those produced by conventional processes by size exclusion chromatography of the products of their hydrolysis with concentrated acid. This is illustrated by FIGS. 1 and 2 of the accompanying drawings in which FIG. 1 is a size exclusion chromatograph of the acid hydrolysis product of a chitosan produced by homogeneous deacetylation while FIG. 2 is a size exclusion chromatograph of the acid hydrolysis product of a chitosan produced by the process of the present invention.
  • the peaks corresponding to monomer, dimer, trimer, etc. progressively decrease in size.
  • the product according to the invention shows a blockwise pattern.
  • the invention provides a chitosan having a degree of acetylation of 0.45 to 0.7 which on acid hydrolysis with 12M HCl for 9 hours at 40° C. yields a monomer and oligomer mixture which in size exclusion chromatography does not exhibit a pattern of progressively smaller peaks corresponding to monomers, dimers, trimers, tetramers, pentamers and hexamers.
  • the chitosan produced by the process of the invention may be used as produced or it may be subject to further chemical or physical modification, e.g. depolymerisation, deacetylation, acetylation, salt formation or other chemical derivatisation, grinding, gel formation, solution formation, fractionation, acid extraction, etc. Typical examples of chitosan derivatisation are widely described in the scientific and patent literature. Conversion to salt form, e.g. by conventional techniques, is a preferred post-production treatment.
  • the chitosan product or modified product can then be used in any of the fields of use previously suggested for chitosans, e.g. in the preparation of technological, agricultural, food (including human food and animal feed and feed additives), nutraceutical, pharmaceutical, biomedical, veterinary and cosmetic products. It is particularly suitable however as a pharmaceutical or veterinary composition, food or cosmetic additive.
  • the invention provides the use of a chitosan product of the process of the invention for the preparation of technological, agricultural, food, nutraceutical, pharmaceutical, biomedical, veterinary and cosmetic products.
  • the invention provides a technological, agricultural, food, nutraceutical, pharmaceutical, biomedical, veterinary or cosmetic product containing a chitosan product of the process of the invention.
  • the yield (as measured by the % acid soluble fraction) increases from 42% with no swelling to 98% with 66 hours of swelling.
  • the chitin was the same as used in Example 1, and was swelled as described in Example 1 at 20° C. for 66 hours.
  • the chemical composition (F A ) of the chitosan can be controlled by the time of deacetylation, and that the product is essentially fully water-soluble when the time of deacetylation is sufficient to obtain an F A of about 0.5 or less.
  • Chitin flakes as supplied by Primex Ingredients (Finnsnes, Norway) for industrial production of chitosans was selected as starting material.
  • the chitin used was flake-like particles with an area of up to 1-2 cm 2 and a flake thickness varying from 20-200 ⁇ m.
  • the dry matter content of the chitin flakes was 20% wt while the water phase had a pH of 12 due to the content of NaOH (aq).
  • the chitosan flake starting material was the same as used in Example 1.
  • This Example serves to demonstrate that the process of the invention can Se used to produce chitosans comparable to those produced using conventional processes.
  • Chitin (as used in Example 1) is swelled for 66 hours at 20° C. as in Example 1. The swelled chitin and unswelled chitin were then deacetylated in 20M NaOH (as in Example 1) at 70, 90 and 120° C.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
US10/485,062 2001-08-02 2002-07-29 Chitosan preparation Abandoned US20040215005A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
NO2001.3802 2001-08-02
NO20013802A NO20013802D0 (no) 2001-08-02 2001-08-02 Fremgangsmåte for fremstilling av kitosaner
NO2001.5986 2001-12-06
NO20015986A NO20015986D0 (no) 2001-08-02 2001-12-06 Produktet chitosan, samt fremstillingsmetode og anvendelse av chitosan
PCT/GB2002/003471 WO2003011912A1 (en) 2001-08-02 2002-07-29 Chitosan preparation

Publications (1)

Publication Number Publication Date
US20040215005A1 true US20040215005A1 (en) 2004-10-28

Family

ID=26649318

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/485,062 Abandoned US20040215005A1 (en) 2001-08-02 2002-07-29 Chitosan preparation

Country Status (12)

Country Link
US (1) US20040215005A1 (no)
EP (1) EP1412391B1 (no)
JP (1) JP2005500410A (no)
CN (1) CN1592756A (no)
AT (1) ATE445648T1 (no)
CA (1) CA2455777A1 (no)
DE (1) DE60234032D1 (no)
IS (1) IS2730B (no)
NO (2) NO20015986D0 (no)
PE (1) PE20030371A1 (no)
SV (1) SV2003001201A (no)
WO (1) WO2003011912A1 (no)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060205932A1 (en) * 2003-06-06 2006-09-14 Venture Chemicals, Inc. Process for the treatment of chitinaceous materials and for the deacetylation of chitin
US20070292903A1 (en) * 2004-11-25 2007-12-20 Takashi Kobayashi Method of detemining tropomyosin in chitosan
US20090075383A1 (en) * 2005-11-04 2009-03-19 Bio Syntech Canada Inc. Composition and method for efficient delivery of nucleic acids to cells using chitosan
US20090275745A1 (en) * 2008-03-19 2009-11-05 Joseph Bristow Chitosan manufacturing process
US20180186899A1 (en) * 2005-06-14 2018-07-05 Genis Hf. Compositions of partially deacetylated chitin derivatives

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1014638A6 (fr) * 2002-02-12 2004-02-03 Univ Liege Methode de preparation de derives de la paroi cellulaire a partir de biomasse.
GB0302741D0 (en) * 2003-02-06 2003-03-12 Advanced Biopolymers As Use
CA2560432C (en) 2004-03-22 2012-10-09 Universite De Geneve Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the same
CA2653390C (en) 2006-06-02 2014-07-08 Hawaii Chitopure, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
ITMI20061373A1 (it) * 2006-07-14 2008-01-15 Sirc S P A Natural & Dietetic Foods Chitine e chitosani in forma attivata e loro proprieta' dimagranti ipoglicemizzanti e ipolipemizzanti
WO2008063503A2 (en) * 2006-11-13 2008-05-29 Hawaii Chitopure, Inc. Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials.
JP5539727B2 (ja) * 2006-12-11 2014-07-02 チット２ジェル リミテッド ヒドロゲルを形成する新規な注入可能なキトサン混合物
US9034348B2 (en) 2006-12-11 2015-05-19 Chi2Gel Ltd. Injectable chitosan mixtures forming hydrogels
US8153612B2 (en) 2006-12-11 2012-04-10 Chi2Gel Ltd. Injectable chitosan mixtures forming hydrogels
RU2605266C2 (ru) 2010-05-04 2016-12-20 Вискогель АБ Композиция хитозана
MX2014009649A (es) 2012-02-15 2015-02-10 Inbicon As Metodo de procesamiento de biomasa lignocelulosica utilizando un control de realimentacion de pre-tratamiento hidrotermico.
CN102617755A (zh) * 2012-04-20 2012-08-01 江南大学 一种用虾壳或虾壳加工残渣制备壳聚糖的简易工艺
GB201316082D0 (en) 2013-09-09 2013-10-23 Viscogel Ab Chitosan composition
JP7069494B2 (ja) * 2017-10-02 2022-05-18 花王株式会社 脱アセチル化キチンの製造方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195175A (en) * 1978-01-03 1980-03-25 Johnson Edwin L Process for the manufacture of chitosan
US4528283A (en) * 1982-06-23 1985-07-09 Wella Aktiengesellschaft Cosmetic composition based upon chitosan derivatives, new chitosan derivatives as well as processes for the production thereof
US4929722A (en) * 1986-06-06 1990-05-29 Union Carbide Chemicals And Plastics Company Inc. Acid decrystallization of aminopolysaccharides and derivatives thereof
US5010181A (en) * 1988-03-28 1991-04-23 Coughlin Robert W Partially treated shellfish waste for removal of heavy metals from aqueous solution
US5453282A (en) * 1992-03-24 1995-09-26 Kirin Beer Kabushiki Kaisha Dietary lipid digestion-absorption inhibitory agents and ingesta
US5733851A (en) * 1995-09-14 1998-03-31 Villanueva; Jaime Formulation and procedure to increase resistance of plants to pathogenic agents and environmental stress

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL142173B1 (en) 1984-04-10 1987-09-30 Morski Inst Rybacki Chemicaly bounded beta-chitin deacetylation process
KR970008132B1 (ko) * 1993-02-08 1997-05-21 전동원 생체 임상의학용 키틴 및 키토산 제조방법
US5599916A (en) 1994-12-22 1997-02-04 Kimberly-Clark Corporation Chitosan salts having improved absorbent properties and process for the preparation thereof
JP2990248B2 (ja) * 1997-06-18 1999-12-13 鳥取県 非晶質の水溶性部分脱アセチル化キチンの製造方法
CA2313836C (en) 2000-03-15 2009-06-09 Cargill, Incorporated Chitosan and method of preparing chitosan

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195175A (en) * 1978-01-03 1980-03-25 Johnson Edwin L Process for the manufacture of chitosan
US4528283A (en) * 1982-06-23 1985-07-09 Wella Aktiengesellschaft Cosmetic composition based upon chitosan derivatives, new chitosan derivatives as well as processes for the production thereof
US4929722A (en) * 1986-06-06 1990-05-29 Union Carbide Chemicals And Plastics Company Inc. Acid decrystallization of aminopolysaccharides and derivatives thereof
US5010181A (en) * 1988-03-28 1991-04-23 Coughlin Robert W Partially treated shellfish waste for removal of heavy metals from aqueous solution
US5453282A (en) * 1992-03-24 1995-09-26 Kirin Beer Kabushiki Kaisha Dietary lipid digestion-absorption inhibitory agents and ingesta
US5733851A (en) * 1995-09-14 1998-03-31 Villanueva; Jaime Formulation and procedure to increase resistance of plants to pathogenic agents and environmental stress

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060205932A1 (en) * 2003-06-06 2006-09-14 Venture Chemicals, Inc. Process for the treatment of chitinaceous materials and for the deacetylation of chitin
US7544785B2 (en) * 2003-06-06 2009-06-09 Venture Chemicals, Inc. Process for the treatment for chitinaceous materials and for the deacetylation of chitin
US20070292903A1 (en) * 2004-11-25 2007-12-20 Takashi Kobayashi Method of detemining tropomyosin in chitosan
US20180186899A1 (en) * 2005-06-14 2018-07-05 Genis Hf. Compositions of partially deacetylated chitin derivatives
US20090075383A1 (en) * 2005-11-04 2009-03-19 Bio Syntech Canada Inc. Composition and method for efficient delivery of nucleic acids to cells using chitosan
US20090275745A1 (en) * 2008-03-19 2009-11-05 Joseph Bristow Chitosan manufacturing process
US8318913B2 (en) 2008-03-19 2012-11-27 Agratech International, Inc. Chitosan manufacturing process

Also Published As

Publication number Publication date
SV2003001201A (es) 2003-03-18
NO332892B1 (no) 2013-01-28
CA2455777A1 (en) 2003-02-13
NO20040381L (no) 2004-03-29
IS2730B (is) 2011-04-15
CN1592756A (zh) 2005-03-09
PE20030371A1 (es) 2003-06-02
WO2003011912A1 (en) 2003-02-13
ATE445648T1 (de) 2009-10-15
JP2005500410A (ja) 2005-01-06
EP1412391B1 (en) 2009-10-14
IS7135A (is) 2004-01-30
NO20015986D0 (no) 2001-12-06
DE60234032D1 (de) 2009-11-26
EP1412391A1 (en) 2004-04-28

Similar Documents

Publication Publication Date Title
EP1412391B1 (en) Chitosan preparation
Nessa et al. A process for the preparation of chitin and chitosan from prawn shell waste
El Knidri et al. Extraction, chemical modification and characterization of chitin and chitosan
Hajji et al. Structural differences between chitin and chitosan extracted from three different marine sources
Yeul et al. Unprecedented chitin and chitosan: A chemical overview
Kumari et al. Extraction and characterization of chitin and chitosan from (Labeo rohit) fish scales
Puvvada et al. Extraction of chitin from chitosan from exoskeleton of shrimp for application in the pharmaceutical industry
Brück et al. Chitin and chitosan from marine organisms
Akakuru et al. The chemistry of chitin and chitosan justifying their nanomedical utilities
Balitaan et al. Marine waste to a functional biomaterial: Green facile synthesis of modified-β-chitin from Uroteuthis duvauceli pens (gladius)
Muslim et al. Chitosan and carboxymethyl chitosan from fish scales of Labeo rohita
Rasweefali et al. Influence of deproteinization and demineralization process sequences on the physicochemical and structural characteristics of chitin isolated from Deep-sea mud shrimp (Solenocera hextii)
Li et al. Hydrogen peroxide pretreatment efficiently assisting enzymatic hydrolysis of chitosan at high concentration for chitooligosaccharides
Al-Hassan Utilization of waste: extraction and characterization of chitosan from shrimp byproducts
Hou et al. Insights into the relationships of modifying methods, structure, functional properties and applications of chitin: A review
Ni’mah et al. Water-soluble chitosan preparation from marine sources
JPS6219897B2 (no)
RU2670767C1 (ru) Способ получения низкомолекулярного гепарина
Ibram et al. Comparison of extraction methods of chitin and chitosan from different sources
CN109400948B (zh) 一种微波过程强化制备不同脱乙酰度和聚合度系列壳低聚糖的方法
Ewais et al. Fully Deacetylated Chitosan From Shrimp And Crab Using Minimum Heat Input
Hasan et al. Preparation of chitin and chitosan
JP7075473B1 (ja) キチン溶解溶媒及びキチン溶出方法
CN113248633A (zh) 一种低分子壳聚糖的制备方法
Kimi et al. Direct extraction of chitosan from snail shells by natural deep eutectic solvent

Legal Events

Date Code Title Description
AS Assignment

Owner name: ADVANCED BIOPOLYMERS AS, NORWAY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:VARUM, KJELL MORTEN;SMIDSROD, OLAV;REEL/FRAME:015538/0838

Effective date: 20040401

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION